The global airway clearance system market size was valued at $652 million in 2018 and is expected to reach $922 million by 2026, registering a CAGR of 4.7% from 2019 to 2026. Airway Clearance techniques (ACTs) are treatment methods that help people suffering with disorders such as cystic fibrosis to attain a healthier lifestyle. ACTs are physical or mechanical means of simplifying the elimination of tracheobronchial phlegm through the external or internal management of air flow, and the removal of phlegm via coughing. These products loosen thick, sticky lung mucus so it can be cleared by coughing. Clearing the mucus from the airways helps in reducing lung infections and improve lung function. These airway clearance devices find their application in the treatment of various disorders including emphysema, cystic fibrosis, neuromuscular, bronchiectasis and others.
Surge in prevalence of cystic fibrosis, asthma, chronic obstructive pulmonary disease (COPD) across the world is the major factor driving the airway clearance system market growth. The major factors driving the market growth are increasing concerns of respiratory diseases, such as asthma and emphysema, and rising incidence of respiratory diseases caused due to cigarette consumption. The growth of the airway clearance system market would be boosted due to increase in healthcare expenditure, growth in the use of automation in healthcare industry, and rapid adoption of advanced medical solutions. Most of healthcare practitioners at present and pulmonary diseases specialists prefer a combination of a drug and a device, for instance inhaler and nebulizer, owing to its fast and effective outcome. However, the airway clearance system market growth could be hindered due to high cost associated with the airway clearance systems and side effects occurring due to excessive dosage, and lack of awareness regarding drug inhalation.
Global Airway Clearnce System Market Segmentation
The airway clearance system market is segmented on the basis of type, application, end user, and region. By type, it is bifurcated into positive expiratory pressure, high frequency chest wall oscillation, oscillating pep devices, intrapulmonary percussive ventilators and mechanical cough assist. Based on application, the market is segregated into emphysema, cystic fibrosis, neuromuscular bronchiectasis. By end-users it is segmented it is classified into hospital & clinics, ambulatory surgical centers, homecare settings and others Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Oscillating PEP devices segment is projected as one of the most lucrative segments.
Type segment review
By type, the positive expiratory pressure segment accounted for 27% of the total airway clearance system market share in 2018 and is expected to exhibit a prominent growth rate in the near future, owing to the fact that it is the most used airway clearance systems used for the treatment of cystic fibrosis. However, oscillating PEP device segment is anticipated to grow at the fastest rate during the forecast period.
Neuromuscular is projected as one of the most lucrative segments.
Application segment review
By application, the bronchiectasis segment dominated the airway clearance system market in 2018 and is anticipated to maintain its dominance during the forecast period. This is attributed to the surge in surge in incidence of the disease across the globe. For instance, according to British Lung Foundation, around 210,000 people in the UK were living with bronchiectasis in 2016.
North America held the largest share in the airway clearance systems market in 2018, followed by Europe. The factors that drive the overall growth of the North American airway clearance systems market include significant increase in cystic fibrosis and increase in government initiates towards increasing awareness regrading COPD, asthma and other chronic respiratory disorders. In addition,presence of leading players of the airway clearance system market such as Hill Rom, Koninklijke Philips N.V., among others contributes to the market growth. Moreover, U.S. and Canada collectively accounted for around 93.8% share in 2018, with the former constituting around 75.5% share. However, Asia-Pacific is anticipated to grow at the highest rate during the analysis period. This is attributed to increase in respiratory disorder patient pool in Asia-Pacific, and significant improvement in the healthcare sector in this region. Moreover, India and China are anticipated to grow at the fastest CAGR during the forecast period, owing to the presence of highest population base; significant surge in demand for the airways clearance systems; and rise in R&D activities in the pharma and medical devices sector in the region.
Comprehensive competitive analysis and profiles of major market players such as Allergan plc, Dymedso Inc., Electromed Inc., Ltd., General Physiotherapy Inc Hill-Rom Holdings, Inc., International Biophysical Corporation, Koninklijke Philips N.V. (Philips), Monaghan Medical Corporation, Inc., and PARI GmbH, Thayer Medical. are provided in this report.
Asia-Pacific region would exhibit the highest CAGR of 6.1% during 2019-2026.
Key Benefits for Stakeholders:
- The airway clearance system market share and analysis is based on a comprehensive analysis of key developments in the airway clearance system industry.
- The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global market.
- The study provides an in-depth analysis of the market trends to elucidate the imminent investment pockets.
- The global airway clearance system market trends are studied from 2018 to 2026.
- Information about key drivers, restrains, and opportunities and their impact analysis on the airway clearance system market size is provided.
- Porter’s five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
- The quantitative analysis of the global airway clearance system market from 2019 to 2026 is provided to determine the market potential.
Airway Clearance System Market Report Highlights
By End User
Key Market Players
International Biophysical Corporation, Electromed Inc., Thayer Medical, Allergan plc, General Physiotherapy Inc, PARI GmbH., Monaghan Medical Corporation, HILL-ROM HOLDINGS, INC., Dymedso Inc, Koninklijke Philips N.V. (Philips)
Airway clearance therapy are used to lighten or loosen the mucus formed in the lungs of the patients suffering from asthma, COPD, cystic fibrosis and others. These devices allow the patients to breathe properly and relieve chest pain by lung expansion and clearing the excessive mucus formation. Further, the increased usage of airway clearance systems for the treatment of bronchiectasis, cystic fibrosis, neuromuscular, is expected to boost the market growth.
The airways clearance systems market is anticipated to witness a steady growth in the future, owing to its increase usage in patients suffering from bronchiectasis. However, high cost of these systems and stringent reimbursement scenario is expected to hamper the market growth in the future. Moreover, North America dominates the market in 2018, owing to the surge in prevalence of respiratory disorders, awareness among patients towards the availability of these devices. Asia-Pacific is anticipated to grow at the fastest growth rate in near future, owing to significant surge in the prevalence of COPD and asthma.